BIOMARIN PHARMACEUTICAL INC
SEC 4 · Filed
0001628280-25-054856Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Dec 1, 2025
Payment of exercise price or tax by delivery of securities by Hardy Alexander
- Security
- Common Stock
- Shares
-
16,570
- Price per share
-
55.03
Structured facts
{
"code": "F",
"date": "2025-12-01",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {},
"owners": [
{
"cik": "0002001910",
"name": "Hardy Alexander",
"roles": [
"director",
"officer"
],
"title": "Chief Executive Officer"
}
],
"ownership": "D",
"post_shares": "159388",
"price": "55.03",
"row": 2,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "16570",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}Insider transactionsEvent date Apr 30, 2025
Grant, award or other acquisition by Hardy Alexander
- Security
- Common Stock
- Shares
-
375
- Price per share
-
54.14
Reported 54.137
Structured facts
{
"code": "A",
"date": "2025-04-30",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer\u0027s Employee Stock Purchase Plan."
},
"owners": [
{
"cik": "0002001910",
"name": "Hardy Alexander",
"roles": [
"director",
"officer"
],
"title": "Chief Executive Officer"
}
],
"ownership": "D",
"post_shares": "175958",
"price": "54.137",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "375",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}